Molecular Diagnostics CEO Adds to His Holdings
13th Sep 2005, 18:19 GMT
Molecular Diagnostics announces that since being named CEO, Dr David Weissberg has increased his holdings in the Company by 1,750,000 shares.
Latest news from Executive Announcements News from myHealthcareNews.com:
- Anika Therapeutics Appoints Constance Garrison as VP of Regulatory and Clinical Affairs
- Accuro Healthcare Solutions Announces New CTO
- Streamline Health named to Forbes Magazine's List of The 200 Best Small Companies for 2006
- Southern Research CEO Jack Secrist Recognized for Contributions in Cancer Drug Research
- Zuckerman named treasurer for CHW
- MQ Assoc Announces Results for Q3 of 2006 and 9 Months Ended 9/30/2006
- KB Home CEO Leaves After Errors Found
- NanoLogix Appoints Global Auto Industry Executive as SVP
- CryoCath named to Deloitte's Technology Fast 500
- Is Your Cat Tight-Lipped When it Comes to His Health? A New Study Finds it's Time to Get Him to Open Wide!